Patients with peripheral arterial disease (PAD) report profound limitations in all domains of quality of life that are worse than those for patients with chronic pulmonary disease and moderate to severe heart failure. While claudication has detrimental effects on quality of life, little is understood about the factors that in uence quality of life and whether these determinants are similar for men and women with PAD and claudication. The purpose of the present investigation was to evaluate the effect of claudication on quality of life in 71 men and 26 women (mean age 72 and 73 years respectively) with PAD. Disease severity as assessed by ankle brachial index (ABI) and community-based walking was similar for men and women, although men reported greater comorbid conditions than women. Despite the similarity in disease severity, women reported decreased physical functioning (p = 0.01), more bodily pain (p = 0.04) and greater mood disturbance (p = 0.012) than men. Claudication and PAD had a greater impact on women than on men and may result from the higher prevalence of mood disturbance and bodily pain reported by women.
Introduction
Peripheral arterial disease (PAD) is a systemic manifestation of atherosclerosis that is associated with a high risk for cardiovascular (CV) morbidity and mortality. 1 The symptoms of PAD are determined in part by the extent of vessel involvement and collateral circulation to the area, and range from leg pain with exertion that is intermittent (claudication; Fontaine class II) to pain at rest and, nally, gangrene (Fontaine class IV). 2 Patients with PAD report profound limitations in all domains of quality of life that are worse than those for patients with chronic pulmonary disease and moderate to severe heart failure. 3 -5 Although claudication has detrimental effects on quality of life, little is understood about the factors that in uence quality of life and whether these determinants are similar for men and women with PAD and claudication. The purpose of the present investigation was to evaluate the effect of claudication on quality of life in men versus women with peripheral arterial disease.
Methods
The current pilot study was conducted as a subanalysis of the larger NO PAIN phase I study. The Nitric Oxide for Peripheral Arterial Insuf ciency (NO PAIN) study, phase I was a randomized double-blind, placebo-controlled trial designed to evaluate the lowest effective dose of l-arginine a School of Nursing, University of California at Los Angeles, CA, USA; b Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA on functional capacity in patients with claudication (Fontaine class II) and peripheral arterial disease. Participants were recruited via citywide media campaign or physician referral.
Sample
Eligibility criteria for participants in this study included (1) age 18 years or older; (2) PAD secondary to atherosclerosis with signi cant claudication (Fontaine class II= intermittent claudication) or critical limb ischemia (Fontaine class III = pain at rest); (3) intermittent claudication characterized by pain, ache, cramp, numbness or severe fatigue involving muscles of one or both lower extremities, reproducibly provoked by walking causing the patient to slow or stop walking pace; (4) ankle brachial index (ABI) ,0.90 and at least a 25% decrease in ABI within 1 minute during exercise recovery; (5) capable of walking at least 2 minutes or 50 feet (15 m); (6) primary limitation to walking is claudication, not coexisting conditions; (7) variability between two (of four) consecutive baseline exercise treadmill tests must be #25%. Subjects were excluded based on the following criteria: (1) PAD of nonatherosclerotic nature; (2) Fontaine class IV = ulcer or gangrene; (3) any type of major surgery during the last three months, i.e., aortic or lower extremity arterial surgery, angioplasty or lumbar sympathectomy; leg amputation above the ankle; (4) myocardial infarction (MI) within the past three months; (5) current enrollment in another clinical trial and/or ingestion of another investigational product within the past 30 days; (6) proliferative retinopathy; (7) history of disease state or surgery that affects gastrointestinal absorption; (8) serum hepatic enzymes three times normal or serum creatinine .3.0 mg/dl; (9) hypersensitivity to arginine; (10) intolerance to sublingual nitroglycerin; (11) uncontrolled hypertension; (12) type I diabetes; (13) active malignancy or tumor; (14) serious infection or hypotension associated with sepsis; (15) cerebrovascular infarct; (16) autoimmune disorders (systemic lupus erythematosis, ulcerative colitis); (17) unwillingness to discontinue concomitant administration of arginine-containing products, pentoxifylline, carnitine or prostacyclin for at least one month prior and during study period.
Evaluation procedures

Ankle brachial index (ABI)
The ABI is a rapid, noninvasive and reliable measure that detects and quanti es PAD. 6 ABI is de ned as the ratio of the ankle systolic blood pressure (SBP) to that in the arm. Studies have shown this method to provide an overall assessment of cardiovascular health and identify individuals who are at particularly high risk for morbidity and mortality. 1 ,7 -9 The sensitivity of the ABI has been reported in clinical trials to be approximately 95%, with a speci city of near 100%. 1 0 ABI was measured in study subjects after 5 min of supine rest. An appropriately sized cuff was placed over the brachial artery to obtain an SBP reading. Another appropriately sized cuff was placed around the ankle, proximal to the malleolus. The cuff was rapidly in ated to 20 mmHg above the audible SBP and de ated over the artery in 2 mm/s increments. Using a hand-held Doppler (Imex Pocket dop-II, Golden, CO, USA) with a 5-MHz probe, blood pressures were obtained in the following sequence: right and left brachial artery followed by right then left dorsalis pedis and right and left posterior tibial pulses. The highest SBP for each of the pulses was used for the calculation of the ankle brachial index. The ABI was calculated for each leg by dividing the posterior tibial or dorsalis pedis SBP in each lower extremity by the upper extremity systolic blood pressure. 6
Exercise performance and walking ability
Exercise treadmill test (ETT)
In order to determine walking ability, all study participants performed an exercise treadmill test using the Skinner-Gardner protocol. 1 1 The Skinner-Gardner protocol consists of a graded workload, with a constant speed of 2 mph (3.2 kph) and an increase in grade of 2% every 2 min. 1 1 ,1 2 During the ETT, standardized verbal encouragement was given and all subjects were continuously monitored for hemodynamic response (heart rate, rhythm and BP) to exercise.
Claudication distance
The initial claudication distance (ICD) was measured as the distance in meters walked on a graded ETT under standardized conditions before the onset of claudication, regardless of whether this was manifested as muscle pain, ache, cramps, numbness or fatigue. The ICD was calculated using results from two consecutive treadmill tests that were less than or equal to 25% variability in absolute claudication distance. 1 2 The absolute claudication distance (ACD) for this study was determined by the point of termination or maximum distance walked on the ETT due to claudication. The ACD was calculated using results from two consecutive treadmill tests that were less than or equal to 25% variability in absolute claudication distance. 1 2 Vascular Medicine 2003; 8: 89-94
Self-reported walking ability
This was assessed with the 11-item Walking Impairment Questionnaire (WIQ) developed by Regensteiner and colleagues. 1 3 The WIQ was designed speci cally for PAD patients to evaluate the effectiveness of various interventions, including physical training, on self-reported walking function. This questionnaire assesses a patient's degree of dif culty with walking de ned distances and speeds as well as rates the severity of claudication pain on usual walking activities. Scores are determined for walking distance, walking speed and stair climbing. The WIQ has been validated with treadmill walking time (r = 0.49; p , 0.05). 1 3 
Quality of life
Quality of life was assessed using the Medical Outcomes Study (MOS) SF-36 instrument. 1 4 This questionnaire includes 36 self-administered items and measures six general health concepts that includes physical functioning (10 items), role-physical (4 items), bodily pain (2 items), general health (5 items), vitality (4 items), social functioning (2 items), role-emotional (3 items), mental health or mood state (5 items) and reported health transition (1 item). Each subscale is standardized and ranges from 0 (worse) to 100 (best possible) function. The SF-36 has been extensively administered to a variety of populations such as patients with diabetes, heart failure and postcoronary bypass surgery and has demonstrated reliability (0.68 to 0.93) and validity. 1 4 ,1 5 Statistical analysis Independent sample Student's t-tests procedures were used to evaluate between group (gender) differences. Medical and surgical history information was analyzed using x 2 tests with Fischer exact test statistics. The a level was set at 0.05 using a two-tailed test of signi cance. Demographic and clinical characteristics of the study sample are reported as means and standard deviations.
Results
Characteristics and comorbidities of cohort
The study population consisted of 71 (73%) men and 26 (27%) women. The mean age for men was 72 (SD = 9) years and 73 (SD = 7) years for women. Characteristics of the sample are shown in Table 1 . The majority were Caucasian, married, well educated and retired.
Comorbidities for this study population included hypertension, hypercholesterolemia, coronary artery disease (CAD), angina, type II diabetes, arthritis, carotid artery stenosis, transient ischemic attacks (TIA), congestive heart failure (CHF), stroke, and renal disease (see Table 2 ). Signi cant differences between men and women were found in the self-report of angina (p = 0.03), CAD (p = 0.04) stroke (p = 0.03) with men reporting higher incidences of these disorders and women reporting greater incidence of hypertension (p = 0.04). Past surgical history includes coronary bypass surgery (CABG), leg bypass, carotid artery surgery, percutaneous transluminal angioplasty (PTCA), abdominal aortic aneurysm (AAA) repair and peripheral angioplasty (see Table 2 ). Men reported a greater number of instances of CABG surgery (p = 0.003), while women reported a greater number of carotid artery operations than men.
Ankle brachial index and exercise performance
All patients had an ABI of less than 0.90 at rest, with a postexercise ABI decrease of at least 25% after maximal exercise. No gender differences were found for ABI (men = 0.64 6 0.17, women = 0.67 6 0.14, p = NS) ( rest or with exercise. The majority of the study population consisted of nonsmokers, who participated in a regular exercise regimen and were on a dietary regimen. All patients discontinued walking on the treadmill because of claudication symptoms that were similar in description and intensity to those experienced in daily activity. No differences between men and women were found for onset of pain, (initial claudication distance). Onset of claudication occurred at 173.04 (6119.00) m for men, and at 130.09 (683.00) m for women, (p = NS). However, men had greater absolute claudication distance on exercise treadmill test than women with peripheral arterial disease. Absolute claudication distance for men was 470.04 (6300.16) m and 314.13 (6176.78) m for women (p = 0.03) ( Table 3 ).
Walking Impairment Questionnaire
The Walking Impairment Questionnaire was administered to assess community-based walking ability, pertinent to patients with PAD. No gender differences were found in distance or speed summary scores (Table 4 ).
In the present study population, there was a positive association between absolute claudication distance and the self-reported community-based Walking Impairment Questionnaire. There was a moderate correlation between total distance walked and initial claudication distance (r = 0.48, p = 0.03) in women, and a moderate to strong relationship between total distance walked and absolute claudication distance (r = 0.65, p = 0.001) in women and men (r = 0.39, p = 0.005). Walking speed was also associated with greater feelings of peace, happiness and calm as measured by the SF-36 (r = 0.25, p = 0.02).
Quality of life
In this study, men and women differed in their perceptions of physical and emotional functioning. Women reported worse physical functioning (p = 0.01), more bodily pain (p = 0.04) and poor mood state (p = 0.012) than men in this study ( Table 4 ).
Discussion
The results of this investigation indicate a gender difference in the perception of pain and limitations of PAD. Women reported lower perceived physical function, mood state and greater bodily pain, despite similar disease severity. In both men and women, quality of life was poor; in fact, it is worse than that reported for patients with moderate to severe heart failure. 5 ,1 6 ,1 7 These results illustrate the detrimental impact 4 Predictors of quality of life in PAD patients include greater disease severity, greater number of comorbidities, pain and older age. 3 -5 ,1 7 -2 0 In the present study, the mean age of men and women were similar. Therefore, while age may have an overall impact on quality of life, it is unlikely that there was a differential effect by gender that would explain the poorer quality of life reported by women in this study. It is likely that other factors associated with aging may have a detrimental effect on quality of life.
Disease severity in the current trial was assessed by ABI. ABIs at rest and after exercise were consistent with the diagnosis of PAD, and no signi cant gender differences were found. Therefore, the ndings from the present study do not support the notion that poorer quality of life in women results from greater disease severity.
Previous studies have observed that lower quality of life is associated with a greater number of medical comorbid conditions and especially associated with stroke. 1 7 ,1 8 Interestingly, in the current study, men had a signi cantly greater number of comorbid medical conditions (CAD, angina and stroke) than women (hypertension and carotid artery surgery). The ndings from the current trial are not consistent with reports of prevalence of stroke and rates of utilization of carotid endardarectomy among men and women. These differences may re ect regional preferences in medical and surgical practice. 2 1 Absolute claudication distance was assessed by treadmill exercise test using the Skinner-Gardner protocol, a graded exercise protocol that is well accepted and widely utilized for assessment of PAD. 2 2 The average time to onset of pain was not different between men and women. However, the absolute claudication distance was greater for men. The difference in absolute claudication distance may be due to sev-Vascular Medicine 2003; 8: 89-94 eral factors, including pain tolerance, motivation and denial, which were not assessed in this study and require further investigation. 2 3 -2 7 No gender differences were observed in self-reported community-based walking ability. Additionally, self-report and objective measures of maximal walking distance were positively associated for women (r = 0.65, p = 0.001) and men (r = 0.39, p = 0.005). This result may be attributed to an impact of gender in both the objective and subjective measurement of walking distance. In this study, some of the older women had dif culty maintaining the 2 mph walking speed during the treadmill exercise test. This may have decreased their maximal walking capacity as measured by the exercise test. However, during normal daily activity they may be able to walk at a more comfortable pace and speed, so that self-reported walking distance is less limited. 2 8 ,2 9 Although there was no gender difference in walking ability, women reported lower physical functioning or performance of activities of daily living and self-care type activities using the SF-36 quality of life questionnaire. These current results are consistent with larger epidemiological studies that show that older women typically report lower physical activity levels than men. These ndings were largely attributed to gender bias of measurement instruments. 2 4 ,3 0 , 3 1 Results from the present study may be attributed to a gender bias in the assessment of physical activity, but may also be due to a gender difference in the perception of the limitation by PAD. 2 4 Additionally, quality of life in the current study may have been adversely affected by the greater bodily pain reported by women than men. Earlier studies show that pain is a strong correlate of quality of life in PAD patients. 3 ,1 8 Interestingly, the source of pain was irrelevant in these earlier trials, and could be due to claudication, back, hip or joint pain. The presence of pain itself was the most important determinant of quality of life. 1 8 The current investigation excluded patients if walking was limited by pain other than claudication, thus, pain was attributable to PAD. However, area of claudication was not assessed and therefore, site of occlusion cannot be inferred. While women reported greater incidence of arthritis than men, these differences and other self-reported joint, musculoskeletal or degenerative comorbid conditions were not statistically signi cant and did not limit functional capacity. However, given the results from previous studies, the presence of arthritis may have contributed to lower quality of life reported by women.
In the current trial, women with PAD and claudication reported worse quality of life than men, given equivalent age, measures of disease burden, and a lesser prevalence of comorbid conditions. Perhaps the key element in this sample of women with PAD was a greater report of bodily pain that may have a signi cant effect on functional capacity and performance of daily activities and ultimately has adverse effects on quality of life. 1 8 ,3 2 Alternatively, a gender difference in mood state may have in uenced the results of this study. This is consistent with an earlier report that found that women with PAD had greater negative feelings than men. 1 8 The women in the current study reported greater mood disturbances as re ected by feelings of nervousness and depression. It is plausible that the greater self-report of bodily pain and limited performance of activities of daily living are a manifestation of mood disturbances and depressive symptoms. 3 3 Of course, the causal relationship between symptoms of PAD and mood disturbance is likely interdependent.
A recent study describes greater depressive symptoms in patients with PAD than in age-matched controls. 3 4 Patients with PAD reported more depression and concomitant reduced community-based walking ability. These researchers concluded that patients with PAD experienced greater functional limitations that contributed to their depressive symptoms. 3 4 This is consistent with studies of older adults that describe an inverse relationship between depression and participation in physical activity. 2 3 In the current investigation, walking speed as assessed by the Walking Impairment Questionnaire was associated with greater feelings of peace, happiness and calm (r = 0.25, p = 0.02).
Social support has also been reported to have bene cial effects on morbidity and mortality in patients postmyocardial infarction. 3 5 While no gender difference was found in marital status, the women in this study were more likely to be widowed than men, hence, this surrogate marker of social support may be an important determinant for the lower quality of life reported by women. 3 6 Clearly, more trials are needed to examine the effects of social support on quality of life in PAD patients.
The present investigation has several limitations that should be considered in interpreting the results. The sample size of women was small and original power calculations were not performed to examine the question of gender differences and quality of life. Therefore, more studies are needed that include a greater number of women with PAD and that speci cally address factors in uencing quality of life. Additionally, the women in this trial were of limited socioeconomic and ethnic background. Future studies should include greater socioeconomically, culturally and ethnically diverse populations of women.
Finally, while the ndings of altered mood state and quality of life are intriguing, clinical depression as de ned by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM IV) criteria was not assessed. 3 7 Vascular Medicine 2003; 8: [89] [90] [91] [92] [93] [94] Future studies are needed that target women with PAD who meet the DSM IV criteria for clinical depression.
In conclusion, this investigation extends the ndings from earlier trials that patients with PAD experience diminished quality of life, and that PAD has a greater impact on women than men. Women report more bodily pain and lower participation in daily activities. This perception may be a consequence, or a cause, of the greater prevalence of mood disturbance observed in women with PAD and claudication.
